Incyte Sacks 37 Percent of Staff as Focus Sharpens on Drug Discovery | GenomeWeb

NEW YORK, Nov. 12 - Incyte Genomics will lay off 259 people, or around 37 percent of its staff, as it embarks on a restructuring program it hopes will shed $88 million in annual costs, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.